Table 2 General clinical and laboratory parameters of all subjects according to serum Asprosin levels

BMI (kg/m²)

24.79 ± 3.75

23.99 ± 3.45

24.14 ± 4

0.411

SBP (mmHg)

125.56 ± 17.11

124.64 ± 17.20

128.69 ± 17.62

0.358

DBP (mmHg)

74.3 ± 11.62

73.8 ± 12.53

73.37 ± 14.12

0.912

TC (mmol/L)

4.72 ± 1.01

4.16 ± 1.15^*

3.84 ± 1.14^*

0.000

TG (mmol/L)

1.2(0.94,1.79)

1.02(0.73,1.41) ^*

1.07(0.81,1.49) ^*

0.010

HDL-C (mmol/L)

1.17 ± 0.28

1.07 ± 0.25

0.98 ± 0.28^*

0.000

LDL-C (mmol/L)

2.67(2.42,3.07)

2.4(1.87,2.92) ^*

2.26(1.61,2.8) ^*

0.000

Apo A1 (g/L)

1.33 ± 0.21

1.23 ± 0.25^*

1.08 ± 0.25^*#

0.000

Apo B (g/L)

0.93(0.78,1.1)

0.83(0.69,1.03)

0.79(0.59,1.03) ^*

0.016

ALT (U/L)

15.69(11.86,22.95)

14.73(10.79,21.82)

13.72(10.59,28.99) ^*#

0.786

AST (U/L)

18.08(15.08,21.23)

18.83(16.04,22.02)

21.12(15.99,26.99) ^*#

0.010

Cr (µmol/L)

66.77 ± 12.62

74.08 ± 16.72^*

82.5 ± 18.68^*#

0.000

BUN (mmol/L)

5.44(4.55,6.54)

5.87(4.94,7.28)

7.03(5.76,9.34) ^*#

0.000

FBG (mmol/L)

5(4.64,5.89)

5.13(4.72,5.74)

5.54(5.01,7.08) ^*#

0.003

HbA1C (%)

5.97 ± 1.58

5.93 ± 1.08

6.68 ± 1.56^*#

0.004

NT-ProBNP (ng/L)

79(36.15,120.88)

113.91(51.91,889.66) ^*

1328(521.18,4663.31) ^*#

0.000

Prevalence of DM

10(14.3%)

15(22.7%)

29(41.4%)^*#

0.001

Prevalence of HBP

27(38.6%)

38(57.6%)^*

53(75.7%)^*#

0.000

Prevalence of CAD

6(8.6%)

31(47%)^*

55(78.6%)^*#

0.000

Prevalence of HF

6(8.6%)

31(47%)^*

66(94.3%)^*#

0.000